Publication: Insight into HIV-1 reverse transcriptase - Aptamer interaction from molecular dynamics simulations
Issued Date
2014-01-01
Resource Type
ISSN
09485023
16102940
16102940
Other identifier(s)
2-s2.0-84904853540
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Molecular Modeling. Vol.20, No.8 (2014)
Suggested Citation
Niran Aeksiri, Napat Songtawee, M. Paul Gleeson, Supa Hannongbua, Kiattawee Choowongkomon Insight into HIV-1 reverse transcriptase - Aptamer interaction from molecular dynamics simulations. Journal of Molecular Modeling. Vol.20, No.8 (2014). doi:10.1007/s00894-014-2380-8 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/33595
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Insight into HIV-1 reverse transcriptase - Aptamer interaction from molecular dynamics simulations
Other Contributor(s)
Abstract
Human immunodeficiency virus-1 reverse transcriptase (HIV-1 RT) is considered to be one of the key targets for antiviral drug therapy. The emergence of the aptamers as potential inhibitors against HIV-1 reverse transcriptase has attracted the attention of the scientific community because these macromolecules can effectively inhibit HIV-1 RT with between micromolar to picomolar concentrations. However, it is not clear how aptamers interact with HIV-1 RT. We have undertaken a molecular dynamics (MD) study in order to gain a keen insight into the conformational dynamics of HIV-1 RT on the formation of a complex with an aptamer or DNA substrate.We have therefore employed three separate models: apo HIV-1 RT, HIV-1 RT with a bound RNA aptamer, and HIV-1 RT with a bound DNA substrate. The results show that HIV-1 RT complex with an aptamer was more stable than that with DNA substrate. It was found that the aptamer interacted with HIV-1 RT in a fingers-and-thumb-closed conformation, at the bound at the nucleic acid substrate binding site. We identified key residues within the HIV-1 RT-aptamer complex in order to help design, develop, and test a new aptamer based on therapies in the future. © Springer-Verlag 2014.